Year: 2021

Saint Herblain (France), December 21, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The VLA1553-302 trial met its primary endpoint, demonstrating that three consecutively manufactured vaccine lots elicited equivalent immune responses measured by neutralizing antibody titer GMT ratios on Day 29 after vaccination. Lot-to-lot trials demonstrate manufacturing consistency, one of the standard requirements for vaccine licensure. The trial, which included 408 participants aged 18 to 45 years, confirmed the excellent immunogenicity profile demonstrated in the pivotal Phase 3 trial, VLA1553-301. All three lots were equally well tolerated and the safety profile was consistent...

Endorsement Applies to: Tauri-Gum™ Product Line   New York, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today received a Product Endorsement Approval Notice (“Product Endorsement”) from the State of Alaska.  Specifically, this Endorsement was issued to the Company by Alaska Division of Agriculture (Industrial Hemp Program).  Endorsement Applies to: Tauri-Gum™ Product Line   This Product Endorsement was issued on December 20, 2021 (AIH Registration Number: E_10119) ABOUT TAURIGA SCIENCES INC. Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary...

Draper Esprit VCT plc (“the Company”)LEI: 2138003I9Q1QPDSQ9Z9721 December 2021Offer for Subscription Update – Overallotment facility The Company is pleased to announce that the offer for subscription that launched on 12 November 2021 (“Offer”) has now raised £18.9 million. The Board has agreed to utilise the overallotment facility of £10 million to extend the total capacity of the Offer to £30 million.

HUNTINGTON BEACH, CA, Dec. 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — One World Universe Inc. (OTC: OWUV), a publicly traded company that invests in sports related businesses, distressed assets, business opportunities within emerging industries such as the Metaverse and providing humanitarian efforts in over 185 countries, has developed its first NFT collection called OneWorld ALIENS Club. This collection from One World Universe hopefully will be the first of many more to come. This 10,000 NFT collection will launch through the LaunchMyNFT.com platform, cofounded by YouTube star “Kwebbelkop” who has 14.9 million YouTube subscribers. The social media superstar will promote the project. A Discord channel has been set up and will serve as a community forum for the NFT project where other NFT holders and shareholders can...

VAYK plans to launch a Version 2.0 of its Vaycaychella P2P Alternative Short-Term Vacation Rental Property Purchase Application by the end of this yearVAYK 2.0 AppVAYK plans to launch a Version 2.0 of its Vaycaychella P2P Alternative Short-Term Vacation Rental Property Purchase Application by the end of this yearVAYK 2.0 AppDallas, Texas, Dec. 21, 2021 (GLOBE NEWSWIRE) — Vaycaychella, Inc. (OTC Pink: VAYK) today announced the company expects to realize approximately $235,000 in revenue this year in 2021. The revenue will result from an interest payment on $1.25 million the company has invested in short-term vacation rental properties. VAYK has established a physical pilot financing the entrepreneurial purchase and operation of short-term rental properties that can be listed on Apps such as Airbnb...

CARY, NC, Dec. 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Small Business Development Group, Inc. (OTC:SBDG) (www.SBDGStock.com) today announced that it will assist Palayan Resources, Inc. (OTC: PLYN), a publicly traded, fully reporting emerging growth company which recently announced it has signed a “Memorandum of Understanding” to acquire a Global FinTech company in the money transfer industry.   That company, which has asked not to be identified as yet, is in the global marketplace. The transaction is subject to standard due diligence including audited financial statements from the FinTech company. “This transaction involves multiple parties, the common thread being C2C Business Strategies, LLC, which serves as a strategic advisor for Palayan Resources,” said Roy Y. Salisbury, Small Business Development Group CEO and...

In Addition, Three Senior Executives Will Reinforce the Company’s Drug Development Engine NANTES, France, Dec. 21, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces the appointment of Laurence de Schoulepnikoff as Chief Business Officer (CBO), as well as three senior appointments to further strengthen the OSE Immunotherapeutics drug development team. Laurence de Schoulepnikoff is a seasoned executive with over 25 years of experience and broad expertise in business development and transactions in the pharmaceutical industry, in particular in driving licensing transactions as well as acquisitions and divestments. Laurence joins OSE Immunotherapeutics from AMAL Therapeutics, a leading Swiss biotechnology company focused on therapeutic cancer vaccines acquired by Boehringer Ingelheim in 2019,...

PRESS RELEASE Neuilly-sur-Seine, France – December 21, 2021 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMFDate Number of shares(1) Number of voting rights30/11/2021 453,228,233 Theoretical number of voting rights: 622,975,751 Number of exercisable voting rights: 622,120,390(1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2021.                Bureau Veritas Head Office Tel.: + 33 (0)1 55 24 70 00Société Anonyme Immeuble Newtime Fax: + 33 (0)1 55 24 70 01(Limited liability corporation) 40/52 boulevard du Parc www.bureauveritas.comShare capital of EUR 54,283,854.36 92200 Neuilly-sur-Seine  RCS Nanterre 775 690 621 France  Attachment...